Swiss Allwyn Entertainment (former Sazka Entertainment), a multinational lottery operator operating lotteries in Austria, the Czech Republic, Greece, Cyprus and Italy, intends to become a publicly-listed company on the NYSE in partnership with Cohn Robbins Holdings, a special purpose acquisition company (SPAC), resulting in an expected total enterprise value for Allwyn Entertainment of approximately USD […]
Distalmotion SA, a young, international medical device company based in Lausanne, successfully closed its USD 90 million Series E financing round led by Revival Healthcare Capital. Distalmotion is a medical device company founded and based in
On January 11, 2022, UBS Group successfully completed its issuance of USD 1.5 bn in aggregate principal amount of Fixed Rate/Fixed Rate Senior Notes due February 2033 and USD 1.5 bn in aggregate principal amount of Fixed Rate/Fixed
Occlutech Holding, a specialist provider of minimally invasive structural heart disease devices, addressing congenital heart defects, stroke prevention and heart failure, has successfully completed a private placement of Swedish Depositary Receipts (SDRs) worth SEK 450 million (
Berner Kantonalbank has successfully completed the placement of CHF 200 m 0.85 per cent. Tier 2 bonds. Zürcher Kantonalbank acted as Structuring Advisor and Lead Manager and Berner Kantonalbank acted as Co-Manager. The bonds will be listed
La Vaudoise Group, through its subsidiary Vaudoise Asset Management, acquires a strategic stake of 20% in the holding company SEG Suisse Estate Group, listed on the Berne Stock Exchange. The main shareholders of SEG keep collectively
MLL has accompanied VanEck ETP in the multicurrency listing of the VanEck Vectors Avalanche ETN (Ticker: VAVA) and the VanEck Vectors Polygon ETN (Ticker: VPOL) on the SIX Swiss Exchange. The new products are trading
Zur Rose Group, e-commerce pharmacy and medical wholesalers, has concluded its accelerated bookbuilding (ABB) with the issuance of 650’000 new shares at an offer price of CHF 290 and gross proceeds of CHF 188.5 million. The shares were
Draupnir Holding, global provider of business decisioning data and analytics, sells 1,500,000 existing ordinary shares in PolyPeptide Group in private placements to institutional investors by way of an accelerated bookbuilding process. The shares, which represent approximately 4.5
RealUnit Schweiz, a Swiss investment company that invests broadly diversified in real assets and shares, has successfully listed more than 18 million bearer shares on the BX Swiss on November 29,2021. Kellerhals Carrard acts as legal counsel
